Glen Santangelo
Stock Analyst at Jefferies
(1.83)
# 3,094
Out of 4,745 analysts
76
Total ratings
45.65%
Success rate
-1.68%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $21.45 | +2.56% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $19.53 | +2.41% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $24.52 | -26.59% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $22.09 | +8.65% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $10.09 | -0.89% | 6 | Sep 17, 2024 | |
| VTRS Viatris | Reinstates: Buy | $15 | $11.20 | +33.93% | 3 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $30.87 | -25.49% | 4 | Jun 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | $19 → $23 | $21.68 | +6.09% | 4 | Jun 27, 2024 | |
| COLL Collegium Pharmaceutical | Upgrades: Buy | $41 → $44 | $32.59 | +35.01% | 3 | Jun 7, 2024 | |
| ELAN Elanco Animal Health | Initiates: Buy | $17 | $12.08 | +40.73% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $168.61 | +36.41% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.72 | +1,283.51% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $36.50 | +91.78% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $6.89 | +103.19% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.89 | +520.91% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $3.45 | +15.94% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.90 | +131.88% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.29 | +325.53% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $6.55 | +1,045.04% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $56.56 | -18.67% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $106.88 | -25.15% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $5.77 | +385.27% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $27.89 | +150.99% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $11.00 | +990.91% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.20 | -37.50% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.95 | +849.49% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.83 | +645.34% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $54.55 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $591.58 | -71.43% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.93 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $128.83 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $74.97 | +9.38% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $233.30 | +7.16% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.87 | +557.12% | 1 | Dec 4, 2017 |
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $21.45
Upside: +2.56%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $19.53
Upside: +2.41%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $24.52
Upside: -26.59%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $22.09
Upside: +8.65%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $10.09
Upside: -0.89%
Viatris
Jul 19, 2024
Reinstates: Buy
Price Target: $15
Current: $11.20
Upside: +33.93%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $30.87
Upside: -25.49%
Teva Pharmaceutical
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $21.68
Upside: +6.09%
Collegium Pharmaceutical
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $32.59
Upside: +35.01%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $12.08
Upside: +40.73%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $168.61
Upside: +36.41%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.72
Upside: +1,283.51%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $36.50
Upside: +91.78%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $6.89
Upside: +103.19%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.89
Upside: +520.91%
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $3.45
Upside: +15.94%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $6.90
Upside: +131.88%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.29
Upside: +325.53%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $6.55
Upside: +1,045.04%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $56.56
Upside: -18.67%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $106.88
Upside: -25.15%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $5.77
Upside: +385.27%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $27.89
Upside: +150.99%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $11.00
Upside: +990.91%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.20
Upside: -37.50%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.95
Upside: +849.49%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.83
Upside: +645.34%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $54.55
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $591.58
Upside: -71.43%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $30.93
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $128.83
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $74.97
Upside: +9.38%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $233.30
Upside: +7.16%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.87
Upside: +557.12%